About Fingolimod Hydrochloride
Class: | Sphingosine 1-phosphate receptor modulator
Use: | Fingolimod Hydrochloride (Finimod Teva) is used for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and delay the accumulation of physical disability.
Adult dose: | The standard adult dose is 0.5 mg orally once daily, with or without food.
Pediatric dose: | For pediatric patients aged 10 years and older, weighing more than 40 kg, the dose is 0.5 mg orally once daily. For th
Drug Class
Sphingosine 1-phosphate receptor modulator
Uses & Indications
Fingolimod Hydrochloride (Finimod Teva) is used for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and delay the accumulation of physical disability.
Storage Requirements
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from moisture and light.
Manufacturer & Packaging
Manufacturer: Teva UK Limited, United Kingdom
Package Size
28's (7's Blister x 4)
Price & Supplier
Price in UAE: AED 5142.50
Dosage Information
Adult Dose
The standard adult dose is 0.5 mg orally once daily, with or without food.
Pediatric Dose
For pediatric patients aged 10 years and older, weighing more than 40 kg, the dose is 0.5 mg orally once daily. For those weighing 40 kg or less, the dose is 0.25 mg orally once daily.
Side Effects
Common side effects include headache, influenza, diarrhea, back pain, liver enzyme elevations, and cough. Other side effects may include bradycardia, hypertension, and macular edema.
Contraindications & Precautions
Fingolimod is contraindicated in patients with recent myocardial infarction, unstable angina, stroke, transient ischemic attack, decompensated heart failure requiring hospitalization, or Class III/IV heart failure. It is also contraindicated in patients with certain types of heart block or sick sinus syndrome unless they have a pacemaker, and in those with a history of hypersensitivity to fingolimod or any of its components.
Important Warnings
Fingolimod may increase the risk of infections, including serious infections. Monitor for signs of infection during treatment and for two months after discontinuation. It can cause macular edema, especially in patients with a history of uveitis or diabetes. Liver function should be monitored due to potential hepatotoxicity. Cardiovascular effects such as bradycardia and hypertension require monitoring, especially after the first dose. Fingolimod may cause fetal harm; women of childbearing potential should use effective contraception during treatment and for two months after stopping the medication.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.